Candidate Sequence Variants and Fetal Hemoglobin in Children with Sickle Cell Disease Treated with Hydroxyurea

• Nancy S. Green ,

  * E-mail: nsg11@columbia.edu

  Affiliation Department of Pediatrics, Columbia University, New York, New York, United States of America

  ⨯
• Katherine L. Ender,

  Affiliation Department of Pediatrics, Columbia University, New York, New York, United States of America

  ⨯
• Farzana Pashankar,

  Affiliation Department of Pediatrics, Yale University, New Haven, Connecticut, United States of America

  ⨯
• Catherine Driscoll,

  Affiliation Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯
• Patricia J. Giardina,

  Affiliation Department of Pediatrics, Weill Cornell University Medical School, New York, New York, United States of America

  ⨯
• Craig A. Mullen,

  Affiliation Department of Pediatrics, University of Rochester, Rochester, New York, United States of America

  ⨯
• Lorraine N. Clark,

  Affiliation Department of Pathology and Cell Biology, Columbia University, New York, New York, United States of America

  ⨯
• Deepa Manwani,

  Affiliation Department of Pediatrics, Albert Einstein College of Medicine, Bronx, New York, United States of America

  ⨯
• Jennifer Crotty,

  Affiliation Department of Pediatrics, Columbia University, New York, New York, United States of America

  ⨯
• Sergey Kisselev,

  Affiliation Department of Pathology and Cell Biology, Columbia University, New York, New York, United States of America

  ⨯
• Kathleen A. Neville,

  Affiliation Department of Pediatrics, Children’s Mercy Hospitals and Clinics, Kansas City, Missouri, United States of America

  ⨯
• Carolyn Hoppe,

  Affiliation Department of Hematology-Oncology, Children’s Hospital and Research Center Oakland, Oakland, California, United States of America

  ⨯
• Sandra Barral

  Affiliation G. H. Sergievsky Center, Columbia University, New York, New York, United States of America

  ⨯